Gerik W. Tushoski-Alemán

Closest collaborators

The 14 strongest of 14 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

1. Song Han · 8 shared papers, 2022–2026 · strength 1.72
   • Paper The Rising Burden of Premature Mortality Due to Pancreatic Cancer in the United States. DOI 10.1097/mpa.0000000000002653↗
   • Paper Variability of quality-of-life measurements and reporting in randomised controlled trials of pancreatic cancer: a syste… DOI 10.1136/bmjopen-2023-083696↗
   • Paper A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. DOI 10.1016/j.neo.2024.101070↗
2. Steven J. Hughes · 8 shared papers, 2022–2026 · strength 1.72
   • Paper The Rising Burden of Premature Mortality Due to Pancreatic Cancer in the United States. DOI 10.1097/mpa.0000000000002653↗
   • Paper Variability of quality-of-life measurements and reporting in randomised controlled trials of pancreatic cancer: a syste… DOI 10.1136/bmjopen-2023-083696↗
   • Paper A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. DOI 10.1016/j.neo.2024.101070↗
3. Kelly M. Herremans · 6 shared papers, 2022–2024 · strength 1.15
   • Paper Variability of quality-of-life measurements and reporting in randomised controlled trials of pancreatic cancer: a syste… DOI 10.1136/bmjopen-2023-083696↗
   • Paper Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer. DOI 10.1371/journal.pone.0297325↗
   • Paper A peek at the other side of the coin: Tumor-suppressor role of microRNAs expressed by pancreatic cancer-associated fibr… DOI 10.1002/ctm2.1357↗
4. Andrea N. Riner · 4 shared papers, 2022–2024 · strength 0.71
   • Paper Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer. DOI 10.1371/journal.pone.0297325↗
   • Paper A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarc… DOI 10.1016/j.pan.2023.06.007↗
   • Paper Single-cell profiling of microenvironment components by spatial localization in pancreatic ductal adenocarcinoma. DOI 10.7150/thno.73222↗
5. Patrick W. Underwood · 3 shared papers, 2022–2024 · strength 0.55
   • Paper Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer. DOI 10.1371/journal.pone.0297325↗
   • Paper A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarc… DOI 10.1016/j.pan.2023.06.007↗
   • Paper The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma. DOI 10.1016/j.neo.2022.100789↗
6. Jose Gilberto Trevino · 2 shared papers, 2024–2025 · strength 0.47
   • Paper A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. DOI 10.1016/j.neo.2024.101070↗
   • Paper Infiltration of CD3+ and CD8+ lymphocytes in association with inflammation and survival in pancreatic cancer. DOI 10.1371/journal.pone.0297325↗
7. Christopher E Forsmark · 2 shared papers, 2023 · strength 0.39
   • Paper A peek at the other side of the coin: Tumor-suppressor role of microRNAs expressed by pancreatic cancer-associated fibr… DOI 10.1002/ctm2.1357↗
   • Paper A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarc… DOI 10.1016/j.pan.2023.06.007↗
8. Jordan A. McKean · 1 shared paper, 2026 · strength 0.33
   • Paper The Rising Burden of Premature Mortality Due to Pancreatic Cancer in the United States. DOI 10.1097/mpa.0000000000002653↗
9. Guangrong Zheng · 1 shared paper, 2025 · strength 0.24
   • Paper A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. DOI 10.1016/j.neo.2024.101070↗
10. Thomas J. George · 1 shared paper, 2025 · strength 0.24
    • Paper A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. DOI 10.1016/j.neo.2024.101070↗
11. Daohong Zhou · 1 shared paper, 2025 · strength 0.24
    • Paper A novel regimen for pancreatic ductal adenocarcinoma targeting MEK, BCL-xL, and EGFR. DOI 10.1016/j.neo.2024.101070↗
12. Ibrahim Nassour · 1 shared paper, 2023 · strength 0.18
    • Paper A protein-based machine learning approach to the identification of inflammatory subtypes in pancreatic ductal adenocarc… DOI 10.1016/j.pan.2023.06.007↗
13. Michael H. Gerber · 1 shared paper, 2022 · strength 0.14
    • Paper The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma. DOI 10.1016/j.neo.2022.100789↗
14. Riley P. Bohan · 1 shared paper, 2022 · strength 0.14
    • Paper The interleukin-1 axis and the tumor immune microenvironment in pancreatic ductal adenocarcinoma. DOI 10.1016/j.neo.2022.100789↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.